<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03360656</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00074620</org_study_id>
    <nct_id>NCT03360656</nct_id>
  </id_info>
  <brief_title>Transnasal Induction of Normothermia in Febrile Stroke Patients</brief_title>
  <official_title>Transnasal Induction of Normothermia in Febrile Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CoolTech LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CoolTech LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate safety and performance of the COOLSTAT® Transnasal
      Thermal Regulating Device in reducing temperature in a population of febrile subjects who
      meet the inclusion/exclusion criteria.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2018</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Temperature reduction</measure>
    <time_frame>8 - 24 hours</time_frame>
    <description>Ability of transnasal thermal regulating device to reduce core body temperature</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke Hemorrhagic</condition>
  <condition>Fever</condition>
  <arm_group>
    <arm_group_label>Transnasal Thermal Regulating Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consented subjects will undergo cooling via transnasal thermal regulating device for a period of 8 to 24 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transnasal Thermal Regulating Device</intervention_name>
    <description>Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours</description>
    <arm_group_label>Transnasal Thermal Regulating Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Admitted to the Neurosciences Critical Care Unit (NCCU).

          2. Patient has ischemic or hemorrhagic stroke.

          3. Patient is orally intubated.

          4. Planned stay in NCCU &gt; 24 hours.

          5. Must have informed consent from the patient or the legally authorized representative
             (LAR)

        Exclusion Criteria:

          1. Age &lt; 18 years old or &gt; 95 years.

          2. Orogastric intubation is contraindicated.

          3. With a coagulopathy. INR above 1.5 or PTT above 45 seconds.

          4. Hemodynamic instability, including elevated SPB for &gt;5 minutes despite standard of
             care interventions (SPB ≥ 160 mmHg for intracerebral hemorrhagic stroke; SPB ≥ 220
             mmHg for subarachnoid hemorrhagic stroke or ischemic stroke).

          5. History of cryoglobulinemia.

          6. History of sickle cell disease.

          7. History of serum cold agglutinin disease.

          8. Active/ongoing of nose bleeds.

          9. Known or suspected pregnancy.

         10. Participation in another ongoing investigational study.

         11. Prisoners and/or patients for whom no LAR is available.

         12. Patient is in airborne/droplet disease isolation protocol.

         13. Patient is or suspected to be immunocompromised;

         14. Low platelet count defined as &lt; 100k (thrombocytopenia).

         15. Nasal septal deviations (per CT scan; any degree).

         16. Chronic rhinosinusitis.

         17. Prior skull-based surgery

         18. Penetrating cranial trauma.

         19. Recent nasal trauma or anterior base skull fracture.

         20. Presence of cardiac arrhythmias including: sustained tachycardia defined as heart rate
             above 120 beats per minute, or sustained bradycardia defined as heart rate below 60
             beats per minute.

         21. Refractory hypoxemia defined as partial pressure of oxygen in arterial blood (paO2)
             below 60 torr or oxyhemoglobin saturation below 90% despite endotracheal intubation,
             mechanical ventilation, and provision of supplemental oxygen of up to 0.60.

         22. Refractory hypercarbia defined as partial pressure of carbon dioxide in arterial blood
             (paCO2) above 50 torr despite endotracheal intubation and conventional mechanical
             ventilation.

         23. History of cardiac arrhythmia as listed above
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neeraj Badjatia, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ of Maryland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neeraj Badjatia, MD MS</last_name>
    <phone>4103284515</phone>
    <email>nbadjatia@umm.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neeraj Badjatia, MD MS</last_name>
      <phone>410-328-4515</phone>
      <email>nbadjatia@umm.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2017</study_first_submitted>
  <study_first_submitted_qc>December 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2017</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland</investigator_affiliation>
    <investigator_full_name>Neeraj Badjatia</investigator_full_name>
    <investigator_title>Professor, Department of Neurology</investigator_title>
  </responsible_party>
  <keyword>shivering, fever, normothermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

